American International Group, Inc. Chroma Dex Corp. Transaction History

American International Group, Inc.

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$1.59 - $2.7 $36,997 - $62,826	-23,269 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$2.02 - $3.92 $3,308 - $6,420	-1,638 Reduced 6.58%	23,269 $57,000
Q4 2021 Feb 11, 2022	SELL	$3.74 - $6.7 $2,786 - $4,991	-745 Reduced 2.9%	24,907 $93,000
Q3 2021 Nov 12, 2021	SELL	$6.05 - $10.41 $3,684 - $6,339	-609 Reduced 2.32%	25,652 $161,000
Q2 2021 Aug 13, 2021	BUY	$6.66 - $10.92 $14,858 - $24,362	2,231 Added 9.28%	26,261 $259,000

Q1 2021 May 07, 2021	BUY	$4.59 - $18.74 $289 - $1,180	63 Added 0.26%	24,030 $224,000
Q4 2020 Feb 12, 2021	SELL	$3.93 - $5.5 $1,591 - $2,227	-405 Reduced 1.66%	23,967 $115,000
Q3 2020 Nov 04, 2020	SELL	$4.01 - $5.56 $2,221 - $3,080	-554 Reduced 2.22%	24,372 $98,000
Q2 2020 Aug 12, 2020	BUY	$3.0 - $5.52 $1,926 - $3,543	642 Added 2.64%	24,926 $114,000
Q1 2020 May 04, 2020	SELL	$2.54 - $4.75 $3,566 - $6,669	-1,404 Reduced 5.47%	24,284 $79,000
Q4 2019 Feb 05, 2020	BUY	$2.83 - $4.61 $2,210 - $3,600	781 Added 3.14%	25,688 $111,000
Q3 2019 Nov 08, 2019	BUY	$3.83 - $4.72 $2,294 - $2,827	599 Added 2.46%	24,907 $98,000
Q2 2019 Aug 13, 2019	SELL	$3.71 - $4.83 $868 - $1,130	-234 Reduced 0.95%	24,308 $113,000
Q1 2019 May 06, 2019	SELL	$3.2 - $4.19 $2,544 - $3,331	-795 Reduced 3.14%	24,542 $103,000
Q4 2018 Feb 13, 2019	SELL	$2.8 - $4.22 $546 - $822	-195 Reduced 0.76%	25,337 $87,000
Q3 2018 Nov 09, 2018	BUY	$3.5 - $4.91 $1,610 - $2,258	460 Added 1.83%	25,532 $110,000
Q2 2018 Aug 08, 2018	BUY	$3.22 - $4.43 $80,731 - $111,068	25,072 New	25,072 $93,000

13.1M

97.1K

17.6K

Ticker CDXC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,350,896
Market Cap $187M
Description
ChromaDex Corporation operates as a bioscience company focusing on healthy aging. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services. It researches on nicotinamide adenine dinucleotide (NAD+); provides finished dietary supplement products that contain its proprietary ingre...

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

Stay updated on American International Group, Inc. with notifications on news.